Tromp Jasper, Wong Michael, Ouwerkerk Wouter, Wu Mei-Zhen, Ren Qing-Wen, Chandramouli Chanchal, Teramoto Kanako, Teng Katherine Tiew-Hwa, Huang Jiayi, To Kelvin-Kai-Wang, Hung Ivan-Fan-Ngai, Tse Hung-Fat, Lam Carolyn S P, Yiu Kai Hang
Saw Swee Hock School of Public Health, National University of Singapore, National University Health System, Singapore, Singapore.
Duke-NUS Medical School, Singapore, Singapore.
Sci Rep. 2024 Dec 28;14(1):30644. doi: 10.1038/s41598-024-65764-0.
COVID-19 can increase the long-term risk of multiorgan dysfunction. Few studies investigated the long-term risk in Asian populations or investigated the association between viral load and long-term risk. We aimed to investigate the post-discharge rates of hospitalization and association with baseline viral load in all patients with COVID-19 in Hong Kong. This was a population-based cohort study included all patients with a positive RT-PCR test for SARS-CoV-2 in Hong Kong between January 1st 2020 and August 30th 2020, routinely admitted to public health care facilities for isolation and treatment. Viral Ct values were available in 3433 (85%) of patients. Outcomes of interest included death, cause-specific hospitalizations, and initiation of medication from the Hospital Authority's territory-wide electronic health records from the Clinical Data Analysis and Reporting System. In total, 4054 people in Hong Kong tested positive for COVID-19 and were admitted to a public health care facility, of whom 167 (4.1%) were admitted to ICU. During a median follow-up time of 251 (interquartile range 240-279) days, 408 (11.9%) were hospitalized for any reason and 16 (0.5%) patients died. After discharge, patients were most often readmitted for respiratory reasons, followed by gastro-intestinal reasons. A higher viral load (lower RT-PCR Ct values) was associated with a higher likelihood of death (Hazard ratio [HR] 5.86, 95% Confidence interval [CI] 2.57-13.33), hospitalization (HR 1.22, 95%CI 1.08-1.39) or hospitalization for cardiovascular disease (HR 12.78, 95%CI 3.67-44.48). Patients with higher viral loads more likely started ACE-inhibitors (HR 1.37, 95%CI 1.12-1.68) and non-opioid analgesics (HR 1.01, 95%CI 1.01-1.23). In a relatively mild COVID-19 population from Hong Kong, the post-acute risk of complications was substantial. Our results highlight that higher viral load predict post-acute complications in patients with relatively mild disease.
新冠病毒疾病(COVID-19)会增加多器官功能障碍的长期风险。很少有研究调查亚洲人群的长期风险,或病毒载量与长期风险之间的关联。我们旨在调查香港所有COVID-19患者出院后的住院率以及与基线病毒载量的关联。这是一项基于人群的队列研究,纳入了2020年1月1日至2020年8月30日期间在香港所有严重急性呼吸综合征冠状病毒2(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)检测呈阳性、常规入住公共卫生保健机构进行隔离和治疗的患者。3433名(85%)患者有病毒Ct值。感兴趣的结局包括死亡、特定病因住院以及从医院管理局临床数据分析和报告系统的全港电子健康记录中获取的用药情况。香港共有4054人COVID-19检测呈阳性并入住公共卫生保健机构,其中167人(4.1%)入住重症监护病房(ICU)。在中位随访时间251天(四分位间距240 - 279天)内,408人(11.9%)因任何原因住院,16人(0.5%)死亡。出院后,患者再次入院最常见的原因是呼吸系统疾病,其次是胃肠道疾病。较高的病毒载量(较低的RT-PCR Ct值)与更高的死亡可能性(风险比[HR] 5.86,95%置信区间[CI] 2.57 - 13.33)、住院(HR 1.22,95%CI 1.08 - 1.39)或因心血管疾病住院(HR 12.78,95%CI 3.67 - 44.48)相关。病毒载量较高的患者更有可能开始使用血管紧张素转换酶抑制剂(ACE抑制剂)(HR 1.37,95%CI 1.12 - 1.68)和非阿片类镇痛药(HR 1.01,95%CI 1.01 - 1.23)。在香港相对轻症的COVID-19人群中,急性后期并发症风险很大。我们的结果表明,较高的病毒载量可预测相对轻症患者的急性后期并发症。